Gold and D-penicillamine induce vasculitis and up-regulate mRNA for IL- 4 in the Brown Norway rat: Support for a role for Th2 cell activity

Clinical and Experimental Immunology

Volumn 108, Issue 3, 1997, Pages 438-445

  Qasim, F J ^a,b   Thiru, S ^a   Gillespie, K ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Brown Norway rat; D penicillamine; gold; IL 4; mercuric chloride; vasculitis

Indexed keywords

GOLD; INTERLEUKIN 4; MESSENGER RNA; PENICILLAMINE;

ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; COMPLICATION; DRUG EFFICACY; DRUG MECHANISM; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; VASCULITIS;

EID: 0030966983     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.2971296.x     Document Type: Article

References (44)

1. Jaffe IA. Penicillamine in rheumatoid arthritis: clinical pharmacology and biochemical properties. Scan J Rheumatol 1979; (Suppl. 28):58-64.
2. 2 in the rat. J Immunol 1981; 126:699-702.
3. 2-induced autoimmunity. J Immunol 1990; 144:2985-91.
4. Donker AJ, Venuto RC, Vladutiu AO et al. Effects of prolonged administration of D-penicillamine or captopril in various strains of rats. Brown Norway rats treated with D-penicillamine develop autoantibodies, circulating immune complexes, and disseminated intravascular coagulation. Clin Immunol Immunopathol 1991; 30:142-55.
5. Tournade H, Guery J-C, Pasquier R et al. Experimental gold-induced autoimmunity. Nephrol Dial Transplant 1991; 6:621-30.
6. Pietsch P, Vohr HW, Degitz K et al. Immunological alterations inducible by mercury compounds II. Mercuric chloride and gold sodium thiomalate enhance serum IgE and IgG in susceptible mouse strains. Int Arch Allergy Appl Immunol 1989; 90:47-53.
7. 2 in the rat, its possible role in an experimental autoimmune disease. Eur J Immunol 1982; 12:620-5.
8. Pelletier L, Pasquier R, Vial M-C et al. Mercury-induced autoimmune glomerulonephritis: requirement for T cells. Nephrol Dial Transplant 1987; 1:211-8.
9. Sapin C, Druet E, Druet P. Induction of anti-glomerular basement membrane antibodies in the Brown-Norway rat by mercuric chloride. Clin Exp Immunol 1977; 28:173-9.
10. Bowman C, Mason DW, Pusey CD et al. Autoregulation of autoantibody synthesis in mercuric chloride nephritis in the Brown Norway rat. I. A role for T suppressor cells. Eur J Immunol 1984; 14:464-70.
11. Guery J-C, Tournade H, Pelletier L et al. Rat anti-glomerular basement membrane antibodies in toxin-induced autoimmunity and in chronic graft-vs.-host reaction share recurrent idiotypes. Eur J Immunol 1990; 20:101-5.
12. Mathieson PW, Thiru S, Oliveira DBG. Mercuric chloride-treated Brown Norway rats develop widespread tissue injury including necrotizing vasculitis. Lab Invest 1992; 67:121-9.
13. Esnault VLM, Mathieson PW, Thiru S et al. Autoantibodies to myeloperoxidase in Brown Norway rats treated with mercuric chloride. Lab Invest 1992; 67:114-20.
14. + T cells in mercury-induced autoimmunity in the Brown Norway rat. J Exp Med 1993; 177:1309-16.
15. Pinching AJ, Rees AJ, Pussell BA et al. Relapses in Wegener's granulomatosis: the role of infection. Br Med J 1980; 281:836-8.
16. Jennette JC, Wilkman AS, Falk RJ. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 1989; 135:921-30.
17. Qasim FJ, Mathieson PW, Thiru S et al. Time course and characterisation of mercuric chloride induced autoimmunity in the Brown Norway rat. J Autoimmun 1995; 8:193-208.
18. Ochel M, Vohr HW, Pfeiffer C et al. IL4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol 1991; 146:3006-11.
19. Gillespie KM, Qasim FJ, Tibbatts LM et al. Interleukin-4 gene expression in mercury-induced autoimmunity. Scand J Immunol 1995; 41:268-72.
20. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducibleTNF-α/cachectin. Nature 1990; 346:274-6.
21. Plaut M, Pierce JH, Watson CJ et al. Mast cell lines produce lymphokines in response to cross-linkage of FcγR1 or to calcium ionophores. Nature 1989; 339:64-7.
22. Oliveira DBG, Gillespie K, Wolfreys K et al. Compounds that induce autoimmunity in the Brown Norway rat sensitize mast cells for mediator release and interleukin-4 expression. Eur J Immunol 1995; 8:2259-64.
23. van der Meide PH, de Labie McDC, Botman CAD et al. Mercuric chloride down-regulates T cell interferon-gamma production in Brown Norway but not in Lewis rats; role of glutathione. Eur J Immunol 1993; 23:675-81.
24. Lipsky PE, Ziff M. The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts. J Immunol 1978; 120:1006-13.
25. Lipsky PE, Ziff M. Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO-4-. J Clin Invest 1980; 65:1069.
26. Emery P, and Panayi GS. Autoimmune reactions to D-penicillamine. In: Kammller ME, Bloksman N, Seinen W, eds. Autoimmunity and toxicology. New York: Elsevier, 1990: 167-82.
27. Fillastre JP, Druet P, Mery JPH. Proteinuric nephropathies associated with drugs and substances of abuse. In: Cameron JS, Glasscock JJ, eds. The nephrotic syndrome. New York: Marcel Dekker, 1989; 697-744.
28. Panayi GS, Wooley P, Batchelor DR. Genetic basis of rheumatoid disease; HLA antigens, disease manifestations and toxic reactions to drugs. Br Med J 1978; 2:1326.
29. Wooley PH, Griffin J, Panayi GS et al. HLA-DR antigens and toxic reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. N Engl J Med 1980; 303:300.
30. Speerstra R, Reekers P, van der Putte LB et al. HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis. J Rheumatol 1983; 10:448-53.
31. Emery P, Panayi GS, Huston G et al. D-penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR. J Rheumatol 1984; 11:626.
32. Katz WA, Blodgett RC, Pietrusko RG. Proteinuria in gold-treated rheumatoid arthritis. Ann Intern Med 1989; 101:176-9.
33. Gibbons RB. Complications of chrysotherapy: a review of recent studies. Arch Intern Med 1979; 46:343-4.
34. Tosi S, Cagnoli M, Guichi G et al. Injectable gold dermatitis and proteinuria: retreatment with auranofin. Int J Clin Pharmacol Res 1985; 4:265-8.
35. Goldman M, Druet P, Gleichmann E. Th2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today 1991; 12:223-7.
36. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
37. Kermarrec N, Dubay C, De Gouyon B et al. Serum IgE concentration and other immune manifestations of treatment with gold salts are linked to the MHC and IL4 regions in the rat. Genomics 1996; 31:111-4.
38. Chalopin JM, Lockwood CM. Autoregulation of autountibody synthesis in mercuric chloride nephritis in the Brown Norway rat. II. Presence of antigen-augmentable plaque-forming cells in the spleen is associated with humoral factors behaving as auto-anti-idiotypic antibodies. Eur J Immunol 1984; 14:470-5.
39. Tournade H, Guery J-C, Pasquier R et al. Effect of the thiol group on experimental gold-induced autoimmunity. Arthritis Rheum 1991; 34:1594-9.
40. Nicotera P, Dypbukt JM, Rossi AD et al. Thiol modification and cell signalling in chemical toxicity. Toxicol Letters 1992; 64:563-7.
41. Janoff A. Elastase in tissue injury. Ann Rev Med 1985; 36:207-16.
42. Meister A, Anderson ME. Glutathione. Ann Rev Biochem 1983; 52: 711-61.
43. Schuhmann D, Kubicka-Muranyi M, Mirtschewa J et al. Adverse immune reactions to gold 1. Chronic treatment with an Au(I) drug sensitises mouse spleen not to Au(I) but to Au(III) and induces autoantibody formation. J Immunol 1990; 145:2132-9.
44. Coleman JW, Buckley MG, Holliday MR et al. Interferon-gamma inhibits serotonin release from mouse peritoneal mast cells. Eur J Immunol 1991; 21:2559-64.